» Articles » PMID: 11035746

Inverse Relation Between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, Among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases

Overview
Journal Infect Immun
Date 2000 Oct 18
PMID 11035746
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

The streptococcal cysteine protease (SpeB) is one of the major virulence factors produced by group A streptococci (GAS). In this study we investigated if differences exist in SpeB production by clonally related M1T1 clinical isolates derived from patients with invasive infections. Twenty-nine of these isolates were from nonsevere cases and 48 were from severe cases, including streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis (NF) cases. The expression and amount of the 28-kDa SpeB protein produced were determined by quantitative Western blotting, and protease activity was measured by a fluorescent enzymatic assay. A high degree of variation in SpeB expression was seen among the isolates, and this variation seemed to correlate with the severity and/or clinical manifestation of the invasive infection. The mean amount of 28-kDa SpeB protein and cysteine protease activity produced by isolates from nonsevere cases was significantly higher than that from STSS cases (P = 0.001). This difference was partly due to the fact that 41% of STSS isolates produced little or no SpeB compared to only 14% of isolates recovered in nonsevere cases. Moreover, the cysteine protease activity among those isolates that expressed SpeB was significantly lower for STSS isolates than for isolates from nonsevere cases (P = 0.001). Increased SpeB production was also inversely correlated with intact M protein expression, and inhibition of cysteine protease activity blocked the cleavage of the surface M protein. Together, the data support the existence of both an "on-off" and a posttranslational regulatory mechanism(s) controlling SpeB production, and they suggest that isolates with the speB gene in the "off" state are more likely to spare the surface M protein and to be isolated from cases of severe rather than nonsevere invasive infection. These findings may have important implications for the role of SpeB in host-pathogen interactions via regulation of the expression of GAS virulence genes and the severity of invasive disease.

Citing Articles

Characterization of a novel SNP identified in Australian group A isolates derived from the M1 lineage.

Richter J, Cork A, Ong Y, Keller N, Hayes A, Schembri M mBio. 2024; 16(2):e0336624.

PMID: 39688411 PMC: 11796353. DOI: 10.1128/mbio.03366-24.


Site-Specific Conjugation of Cell Wall Polyrhamnose to Protein SpyAD Envisioning a Safe Universal Group A Streptococcal Vaccine.

Gao N, Uchiyama S, Pill L, Dahesh S, Olson J, Bautista L Infect Microbes Dis. 2024; 3(2):87-100.

PMID: 39450141 PMC: 11501091. DOI: 10.1097/im9.0000000000000044.


A genome-scale metabolic model of a globally disseminated hyperinvasive M1 strain of .

Hirose Y, Zielinski D, Poudel S, Rychel K, Baker J, Toya Y mSystems. 2024; 9(9):e0073624.

PMID: 39158303 PMC: 11406949. DOI: 10.1128/msystems.00736-24.


Reduced interleukin-18 secretion by human monocytic cells in response to infections with hyper-virulent Streptococcus pyogenes.

Tolken L, Paulikat A, Jachmann L, Reder A, Salazar M, Palma Medina L J Biomed Sci. 2024; 31(1):26.

PMID: 38408992 PMC: 10898077. DOI: 10.1186/s12929-024-01014-9.


Immunomodulating Enzymes from -In Pathogenesis, as Biotechnological Tools, and as Biological Drugs.

Happonen L, Collin M Microorganisms. 2024; 12(1).

PMID: 38258026 PMC: 10818452. DOI: 10.3390/microorganisms12010200.


References
1.
Lyon W, Gibson C, Caparon M . A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J. 1998; 17(21):6263-75. PMC: 1170952. DOI: 10.1093/emboj/17.21.6263. View

2.
Raeder R, Woischnik M, Podbielski A, Boyle M . A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol. 1998; 149(8):539-48. DOI: 10.1016/s0923-2508(99)80001-1. View

3.
Lukomski S, MONTGOMERY C, Rurangirwa J, Geske R, Barrish J, Adams G . Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun. 1999; 67(4):1779-88. PMC: 96528. DOI: 10.1128/IAI.67.4.1779-1788.1999. View

4.
Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low D, Schwartz B . Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun. 1999; 67(4):1871-7. PMC: 96540. DOI: 10.1128/IAI.67.4.1871-1877.1999. View

5.
Rasmussen M, Muller H, Bjorck L . Protein GRAB of streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J Biol Chem. 1999; 274(22):15336-44. DOI: 10.1074/jbc.274.22.15336. View